Life Sciences: Advanced Analytics

Advanced Analytics

CRA has the analytical tools and market experience needed to make the most of your one and only product launch opportunity. CRA helps companies develop superior commercial strategies based on sound market fundamentals – from launch strategy to portfolio optimization to franchise expansion.

Our advantage

  • 25+ team members entirely focused on advanced analytics within pharma
  • Innovative approaches built over 10+ years in the space
  • Integration across consulting teams to maximize effectiveness
  • Secondary data capabilities are source agnostic and delivered by a dedicated team of analytics experts skilled in extracting unique insights for evidence-based decision making around product launches

Strategic expertise

Our analytics solutions support clients throughout the product lifecycle.

Pipeline planning
  • Longitudinal patient journey
  • Market maps / cross-sectional analysis
  • Opportunity assessments
  • BD support / due diligence
  • Forecasting
Launch preparation
  • Patient finding and imputation
  • Key behavioral influencers
  • Receptivity analysis
  • Physician segmentation and targeting
  • Simulation
  • KPI Identification and Tracking
Marketed products
  • Economic value proposition
  • Persistency and compliance tracking
  • Dispense as written analysis
  • ROI / promotional response
  • Payer / access analysis

Sample engagements

Using data and analytics to prepare for disease area entry
Go-to-market strategy for follow-on asset with blockbuster potential
Maximizing new oncology launch
Maximize a new product in crowded and generic marketplace
Buying process for under-performing rare disease product

Our life sciences practice is made up of 185 consultants that blend decades of global business experience with an extensive understanding of life sciences.

Meet our senior team >